subcutaneous rituximab

May 16, 2017

Injected Rituxan Is as Effective and Safe as IV Form as Lymphoma Treatment, Study Concludes

News

Injections of Rituxan (rituximab) for non-Hodgkin lymphoma are as effective as intravenous administrations, take five minutes instead of an hour and a half, and require far less medical-staff monitoring time, according to ... Read more

March 31, 2017

Injected Version of Rituximab for Cancer Treatment Is One Step Away from U.S. Approval

News

An injected formulation of rituximab and hyaluronidase for treating certain blood cancers is one step away from U.S. approval. The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee has recommended the ... Read more